1)Takigawa M, Takahashi A, Kuwahara T, et al. Impact of Non-Pulmonary Vein Foci on the Outcome of the Second Session of Catheter Ablation for Paroxysmal Atrial Fibrillation. J Cardiovasc Electrophysiol 2015 ; 26 : 739-46.
2)Hayashi K, An Y, Nagashima M, et al. Importance of nonpulmonary vein foci in catheter ablation for paroxysmal atrial fibrillation. Heart Rhythm 2015 ; 12 : 1918-24.
3)Hirokami J, Hiroshima K, Yamaji K, et al. Relationship Between Fractionated Signal Areas in the Atrial Muscle During Sinus Rhythm and Atrial Pacing and Non-Pulmonary Vein Foci : Novel Mapping Strategy. Circ Arrhythm Electrophysiol 2020 ; 13 : e008667.
4)Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015 ; 372 : 1812-22.
5)Fink T, Schlüter M, Heeger CH, et al. Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation : The Randomized Alster-Lost-AF Trial(Ablation at St. Georg Hospital for Long-Standing Persistent Atrial Fibrillation). Circ Arrhythm Electrophysiol 2017 ; 10 : e005114.
6)Vogler J, Willems S, Sultan A, et al. Pulmonary Vein Isolation Versus Defragmentation : The CHASE-AF Clinical Trial. J Am Coll Cardiol 2015 ; 66 : 2743-52.
7)Waranugraha Y, Rizal A, Setiawan D, et al. Additional complex fractionated atrial electrogram ablation does not improve the outcomes of non-paroxysmal atrial fibrillation : A systematic review and meta-analysis of randomized controlled trials. Indian Heart J 2021 ; 73 : 63-73.
8)Inoue K, Hikoso S, Masuda M, et al. Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation : the EARNEST-PVI trial. Europace 2021 ; 23 : 565-74.
9)Kistler PM, Chieng D, Sugumar H, et al. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation : The CAPLA Randomized Clinical Trial. JAMA 2023 ; 329 : 127-35.
10)Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device : Results From the AATAC Multicenter Randomized Trial. Circulation 2016 ; 133 : 1637-44.
11)Ahn J, Shin DG, Han SJ, et al. Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial. Europace 2022 ; 24 : 1093-101.
12)Yamaji H, Higashiya S, Murakami T, et al. Efficacy of an Adjunctive Electrophysiological Test-Guided Left Atrial Posterior Wall Isolation in Persistent Atrial Fibrillation Without a Left Atrial Low-Voltage Area. Circ Arrhythm Electrophysiol 2020 ; 13 : e008191.
13)Cutler MJ, Johnson J, Abozguia K, et al. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol 2016 ; 27 : 13-21.
14)Bai R, Di Biase L, Mohanty P, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm 2016 ; 13 : 132-40.
15)Segan L, Chieng D, Prabhu S, et al. Posterior Wall Isolation Improves Outcomes for Persistent AF With Rapid Posterior Wall Activity : CAPLA Substudy. JACC Clin Electrophysiol 2023 ; 9 : 2536-46.
16)Jiang X, Liao J, Ling Z, et al. Adjunctive Left Atrial Posterior Wall Isolation in Treating Atrial Fibrillation : Insight From a Large Secondary Analysis. JACC Clin Electrophysiol 2022 ; 8 : 605-18.
17)Turagam MK, Neuzil P, Schmidt B, et al. Impact of Left Atrial Posterior Wall Ablation During Pulsed-Field Ablation for Persistent Atrial Fibrillation. JACC Clin Electrophysiol 2024 : S2405-500X(24)00030-6. Online ahead of print.
18)Masuda M, Asai M, Iida O, et al. Additional Low-Voltage-Area Ablation in Patients With Paroxysmal Atrial Fibrillation : Results of the Randomized Controlled VOLCANO Trial. J Am Heart Assoc 2020 ; 9 : e015927.
19)Yang G, Zheng L, Jiang C, et al. Circumferential Pulmonary Vein Isolation Plus Low-Voltage Area Modification in Persistent Atrial Fibrillation : The STABLE-SR-II Trial. JACC Clin Electrophysiol 2022 ; 8 : 882-91.
20)Huo Y, Gaspar T, Schonbauer R, et al. Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation. NEJM Evid 2022 ; 1 : EVIDoa2200141.
21)Kircher S, Arya A, Altmann D, et al. Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation : a randomized study. Europace 2018 ; 20 : 1766-75.
22)Junarta J, Siddiqui MU, Riley JM, et al. Low-voltage area substrate modification for atrial fibrillation ablation : a systematic review and meta-analysis of clinical trials. Europace 2022 ; 24 : 1585-98.
23)Hwang C, Chen PS. Ligament of Marshall : why it is important for atrial fibrillation ablation. Heart Rhythm 2009 ; 6(12 Suppl): S35-40.
24)Valderrabano M, Peterson LE, Swarup V, et al. Effect of Catheter Ablation With Vein of Marshall Ethanol Infusion vs Catheter Ablation Alone on Persistent Atrial Fibrillation : The VENUS Randomized Clinical Trial. JAMA 2020 ; 324 : 1620-8.
25)Ge WL, Li T, Lu YF, et al. Efficacy and feasibility of vein of Marshall ethanol infusion during persistent atrial fibrillation ablation : A systematic review and meta-analysis. Clin Cardiol 2024 ; 47 : e24178.